Detecting Anosognosia from the Prodromal Stage of Alzheimer's Disease.
Alzheimer’s disease
HABC-M
anosognosia assessment
caregiver burden
error-monitoring
timely diagnosis
Journal
Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863
Informations de publication
Date de publication:
2023
2023
Historique:
medline:
23
10
2023
pubmed:
18
9
2023
entrez:
18
9
2023
Statut:
ppublish
Résumé
Though not originally developed for this purpose, the Healthy Aging Brain Care Monitor (HABC-M) seems a valuable instrument for assessing anosognosia in Alzheimer's disease (AD). Our study aimed at 1) investigating the validity of the HABC-M (31 items), and its cognitive, psychological, and functional subscales, in discriminating AD patients from controls; 2) exploring whether the HABC-M discrepancy scores between the self-reports of patients/controls in these different domains and the respective ratings provided by their caregivers/informants correlate with an online measure of self-awareness; 3) determining whether the caregiver burden level, also derived from the HABC-M, could add additional support for detecting anosognosia. The HABC-M was administered to 30 AD patients and 30 healthy controls, and to their caregivers/informants. A measure of online awareness was established from subjects' estimation of their performances in a computerized experiment. The HABC-M discrepancy scores distinguished AD patients from controls. The cognitive subscale discriminated the two groups from the prodromal AD stage, with an AUC of 0.88 [95% CI: 0.78;0.97]. Adding the caregiver burden level raised it to 0.94 [0.86;0.99]. Significant correlations between the HABC-M and online discrepancy scores were observed in the patients group, providing convergent validity of these methods. The cognitive HABC-M (six items) can detect anosognosia across the AD spectrum. The caregiver burden (four items) may corroborate the suspicion of anosognosia. The short-hybrid scale, built from these 10 items instead of the usual 31, showed the highest sensitivity for detecting anosognosia from the prodromal AD stage, which may further help with timely diagnosis.
Sections du résumé
BACKGROUND
Though not originally developed for this purpose, the Healthy Aging Brain Care Monitor (HABC-M) seems a valuable instrument for assessing anosognosia in Alzheimer's disease (AD).
OBJECTIVES
Our study aimed at 1) investigating the validity of the HABC-M (31 items), and its cognitive, psychological, and functional subscales, in discriminating AD patients from controls; 2) exploring whether the HABC-M discrepancy scores between the self-reports of patients/controls in these different domains and the respective ratings provided by their caregivers/informants correlate with an online measure of self-awareness; 3) determining whether the caregiver burden level, also derived from the HABC-M, could add additional support for detecting anosognosia.
METHODS
The HABC-M was administered to 30 AD patients and 30 healthy controls, and to their caregivers/informants. A measure of online awareness was established from subjects' estimation of their performances in a computerized experiment.
RESULTS
The HABC-M discrepancy scores distinguished AD patients from controls. The cognitive subscale discriminated the two groups from the prodromal AD stage, with an AUC of 0.88 [95% CI: 0.78;0.97]. Adding the caregiver burden level raised it to 0.94 [0.86;0.99]. Significant correlations between the HABC-M and online discrepancy scores were observed in the patients group, providing convergent validity of these methods.
CONCLUSIONS
The cognitive HABC-M (six items) can detect anosognosia across the AD spectrum. The caregiver burden (four items) may corroborate the suspicion of anosognosia. The short-hybrid scale, built from these 10 items instead of the usual 31, showed the highest sensitivity for detecting anosognosia from the prodromal AD stage, which may further help with timely diagnosis.
Identifiants
pubmed: 37718816
pii: JAD230552
doi: 10.3233/JAD-230552
pmc: PMC10578267
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1723-1733Subventions
Organisme : NIA NIH HHS
ID : RF1 AG074204
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG079324
Pays : United States
Références
Int J Geriatr Psychiatry. 2016 Jul;31(7):799-808
pubmed: 26643996
Int J Geriatr Psychiatry. 2013 Mar;28(3):291-7
pubmed: 22555993
Br J Clin Psychol. 2004 Jun;43(Pt 2):177-196
pubmed: 15169617
Eur J Neurol. 2007 Apr;14(4):455-60
pubmed: 17388998
Cortex. 2014 Dec;61:5-8
pubmed: 25481462
Front Hum Neurosci. 2013 Dec 05;7:830
pubmed: 24367313
Front Psychiatry. 2021 Mar 31;12:631518
pubmed: 33868048
Cortex. 2007 Oct;43(7):1020-30
pubmed: 17941357
Int J Alzheimers Dis. 2011;2011:483897
pubmed: 21660200
J Alzheimers Dis. 2016 May 31;53(3):1133-43
pubmed: 27258415
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
J Neuropsychiatry Clin Neurosci. 1992 Spring;4(2):134-9
pubmed: 1627973
Neuropsychologia. 2011 Jul;49(9):2609-18
pubmed: 21620877
Neurology. 2018 Mar 13;90(11):e932-e939
pubmed: 29444971
Cortex. 2014 Dec;61:64-73
pubmed: 25481465
Alzheimer Dis Assoc Disord. 1996 Summer;10(2):68-76
pubmed: 8727167
Int J Geriatr Psychiatry. 2014 Aug;29(8):852-62
pubmed: 24753076
Neurology. 2000 Dec 12;55(11):1621-6
pubmed: 11113214
Gerontologist. 1980 Dec;20(6):649-55
pubmed: 7203086
Front Hum Neurosci. 2020 Jan 09;13:453
pubmed: 31998101
Alzheimers Dement (Amst). 2020 Sep 30;12(1):e12079
pubmed: 33024810
Clin Interv Aging. 2012;7:143-57
pubmed: 22791987
Lancet Neurol. 2014 Jun;13(6):614-29
pubmed: 24849862
J Int Neuropsychol Soc. 2010 May;16(3):463-73
pubmed: 20188013
J Geriatr Psychiatry Neurol. 2014 Sep;27(3):220-6
pubmed: 24700707
J Neurol Neurosurg Psychiatry. 2006 Jun;77(6):719-25
pubmed: 16549411
Curr Neurol Neurosci Rep. 2017 Mar;17(3):27
pubmed: 28283961
J Psychiatr Res. 1982-1983;17(1):37-49
pubmed: 7183759
Clin Interv Aging. 2014 Dec 05;9:2123-32
pubmed: 25584024
Cortex. 2023 Sep;166:428-440
pubmed: 37423786
J Alzheimers Dis. 2017;59(2):753-762
pubmed: 28671134
Alzheimer Dis Assoc Disord. 1999 Jul-Sep;13(3):151-6
pubmed: 10485574